We are live on ! Find out more
HCM

Heights Capital Management Portfolio holdings

AUM $359M
1-Year Est. Return 7.93%
This Fund
S&P 500
This Quarter Est. Return
-11.02%
1 Year Est. Return
+7.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$359M
AUM Growth
+$79.9M
Cap. Flow
+$141M
Cap. Flow %
39.38%
Top 10 Hldgs %
39.09%
Holding
330
New
138
Increased
Reduced
27
Closed
65

Sector Composition

Rank Sector Weight
1 Financials 46.82%
2 Consumer Discretionary 19.91%
3 Technology 8.99%
4 Healthcare 4.76%
5 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUMAU
151
SUMA Acquisition Corp Units
SUMAU
$301K 0.08%
+30,000
New +$300K
BCTXL
152
BriaCell Therapeutics Warrant
BCTXL
$2.29M
$300K 0.08%
+300,000
New +$318K
POLE
153
Andretti Acquisition Corp II
POLE
$318M
$283K 0.08%
26,600
NTWO
154
Newbury Street II Acquisition Corp
NTWO
$276K 0.08%
26,191
-4,319
-14% -$45.3K
TVA
155
Texas Ventures Acquisition III Corp
TVA
$315M
$269K 0.08%
25,900
MODD icon
156
Modular Medical
MODD
$12.7M
$264K 0.07%
+50,000
New +$536K
SSACU
157
SPACSphere Acquisition Corp Unit
SSACU
$252K 0.07%
+25,000
New +$252K
BCAR
158
D. Boral ARC Acquisition I Corp
BCAR
$233M
$251K 0.07%
24,757
APXT
159
Apex Treasury Corp
APXT
$465M
$250K 0.07%
+25,000
New +$249K
CMIIU
160
Columbus Circle Capital Corp II Unit
CMIIU
$249K 0.07%
+25,000
New +$250K
AACOU
161
Abony Acquisition Corp I Units
AACOU
$249K 0.07%
+25,000
New +$249K
TLNC
162
Talon Capital Corp
TLNC
$349M
$247K 0.07%
+24,104
New +$244K
LPCVU
163
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
$201M
$200K 0.06%
20,000
ACAAU
164
Averin Capital Acquisition Corp Units
ACAAU
$200K 0.06%
+20,000
New +$201K
EURK
165
Eureka Acquisition Corp
EURK
$26.5M
$175K 0.05%
15,400
LATA
166
Galata Acquisition Corp II
LATA
$233M
$150K 0.04%
+15,000
New +$150K
HAVA
167
Harvard Ave Acquisition Corp
HAVA
$210M
$100K 0.03%
+10,000
New +$99.9K
BBCQW
168
Bleichroeder Acquisition Corp II Warrants
BBCQW
$88.6K 0.02%
+93,182
New +$69.9K
NMPAR
169
NMP Acquisition Corp Right
NMPAR
$87.9K 0.02%
439,562
-10,313
-2% -$2.16K
AMPGR
170
DELISTED
Amplitech Group Series A Right
AMPGR
$86.1K 0.02%
+1,230,000
New +$204K
JACS.RT
171
Jackson Acquisition Co II Rights
JACS.RT
$80.9K 0.02%
700,000
BCTXZ
172
BriaCell Therapeutics Corp Warrant
BCTXZ
$210K
$75.6K 0.02%
540,098
-4,600
-0.8% -$772
AMPGZ
173
Amplitech Group Series B Right
AMPGZ
$75K 0.02%
+1,230,000
New +$254K
AIIA.RT
174
AI Infrastructure Acquisition Corp Rights
AIIA.RT
$75K 0.02%
+300,000
New +$79.2K
KCHVR
175
Kochav Defense Acquisition Corp Right
KCHVR
$72.8K 0.02%
306,546
-54,363
-15% -$13.9K

Similar funds

Heights Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Heights Capital Management held 330 positions worth $359M, up 29% from $279M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Heights Capital Management deployed $141M of net new capital in Q1 2026, opening 138 new positions. Its largest new stake was Solid Power: 12,395,558 shares worth $37.2M.

By sector, the portfolio is most concentrated in Financials at 47% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Nyxoah, an estimated $1.98M trimmed.

  • Heights Capital Management's largest Q1 2026 buy was Solid Power: 12,395,558 shares worth $37.2M.
  • Heights Capital Management's biggest Q1 2026 reduction was Nyxoah, cutting an estimated $1.98M.
  • Heights Capital Management fully exited Drugs Made In America Acquisition II Corp Unit in Q1 2026, selling an estimated $5.19M.
  • Heights Capital Management's ten largest holdings make up 39% of its $359M portfolio in Q1 2026.
  • Heights Capital Management opened 138 new positions and closed 65 in Q1 2026.
  • Heights Capital Management's portfolio value rose 29% quarter-over-quarter to $359M.

Based on Heights Capital Management's 13F filing for Q1 2026, filed 15 May 2026.